DJIA 18,203.37 -85.26 -0.47%
NASDAQ 4,979.90 0.00 0.00%
S&P 500 2,107.78 -9.61 -0.45%
market minute promo

7.64 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $8.20 $0.56 (7.33%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

OREX $7.64 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $7.64
Daily Range $0.00 - $0.00
52-Week Range $3.11 - $9.37
Market Cap $945.3M
P/E Ratio -23.88
Dividend (Yield) $0.00 (0.0%)
Volume 51,260
Average Daily Volume 5,061,489
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drug Makers

Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website: http://www.orexigen.com/

News & Commentary Rss Feed

Why Arena Pharmaceuticals, Inc. Burst Today

Arena Pharmaceuticals shares slumped after reporting lackluster earnings and competitors positive news.

Report: Orexigen Therapeutics Jumped Gun On Contrave Heart Study

Short Squeeze At Orexigen Gives Profit Opportunity For Longs

Why Orexigen Therapeutics, Inc. Stock Exploded Higher

Orexigen Therapeutics looks like it has the first game-changing obesity drug on its hands. Here's what you need to know.

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Arena Pharmaceuticals, Inc. Earnings: Explaining the Wonky Trends

A fourth-quarter slowdown and relatively flat sales over the year.

Vivus - Flat Qsymia Scripts Point To Needed Shift

Orexigen's Earnings Report Gives Clarity On Future Revenues

Orexigen's Q4 Results Disappoint, But Contrave Is Gaining Market Share

See More OREX News...

OREX's Top Competitors

OREX $7.64 (0.00%)
Current stock: OREX
AMGN $158.56 (0.00%)
Current stock: AMGN
GILD $102.79 (0.00%)
Current stock: GILD
BIIB $412.79 (0.00%)
Current stock: BIIB